Laurus Labs Limited (NSE:LAURUSLABS)
1,609.00
+40.70 (2.60%)
Jul 24, 2026, 3:30 PM IST
Laurus Labs Revenue
Laurus Labs had revenue of 20.26B INR in the quarter ending June 30, 2026, with 29.10% growth. This brings the company's revenue in the last twelve months to 72.70B, up 22.62% year-over-year. In the fiscal year ending March 31, 2026, Laurus Labs had annual revenue of 68.13B with 22.67% growth.
Revenue (ttm)
72.70B
Revenue Growth
+22.62%
P/S Ratio
11.89
Revenue / Employee
10.30M
Employees
7,059
Market Cap
864.42B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 68.13B | 12.59B | 22.67% |
| Mar 31, 2025 | 55.54B | 5.13B | 10.18% |
| Mar 31, 2024 | 50.41B | -10.00B | -16.55% |
| Mar 31, 2023 | 60.41B | 11.05B | 22.39% |
| Mar 31, 2022 | 49.36B | 1.22B | 2.54% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 336.53B |
| Cipla | 280.68B |
| Zydus Lifesciences | 271.48B |
| Glenmark Pharmaceuticals | 169.83B |
| Alkem Laboratories | 147.12B |
| Mankind Pharma | 142.78B |
| Divi's Laboratories | 105.60B |
| Ipca Laboratories | 96.47B |
Laurus Labs News
- 1 day ago - Laurus Labs Q1 net profit surges 126% - The Times of India
- 1 day ago - Laurus Labs Transcript: Q1 26/27 - Transcripts
- 1 day ago - Laurus Labs Quarterly report: Q1 2027 - Filings
- 1 day ago - Laurus Labs Slides: Q1 2027 - Filings
- 19 days ago - Laurus Labs announces conclusion of Aruna Bhinge's tenure as independent director - Business Upturn
- 23 days ago - Laurus Labs appoints Dr. Shekhar Chintamani Mande and Ms. Sutapa Banerjee as independent directors - Business Upturn
- 23 days ago - Laurus Labs Transcript: AGM 2026 - Transcripts
- 27 days ago - Nifty rebalancing today: MCX, NTPC, Laurus Labs among top inflow beneficiaries; Bharti Airtel, Eicher Motors face highest outflows - Business Upturn